The Notch pathway as a biomarker in pancreatic ductal adenocarcinoma and its potential therapeutic modulation
Pancreatic ductal adenocarcinoma (PDAC) is the 5th commonest cause of cancer related deaths in the UK and has a poor prognosis with 1-year survival of only 10%. Improved understanding of pancreatic carcinogenesis would allow identification of biomarkers to predict disease progression, prognosis, and...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Leicester
2012
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.556293 |